Congenital Heart Disease
Conditions
Brief summary
Advanced surgical and medical healthcare systems have resulted in an increased prevalence of children and adults with congenital heart disease in Western countries. These patients often necessitate non-cardiac interventions. Previous studies have demonstrated that these patients are at increased risk of morbidity and mortality when presenting for non-cardiac interventions. The aim of this study is to know the prevalence of patients with congenital heart disease presenting for non-cardiac interventions in a tertiary hospital and to determine their outcome.
Detailed description
Previous studies have shown that children and adults presenting with congenital heart disease are at increased risk of morbidity and mortality after non-cardiac interventions. This risk depends on the type of pathology, the age of the patient and the experience of the physicians in charge of these patients. We sought to determine the prevalence of children and adults with congenital heart disease presenting for non-cardiac interventions and to investigate their outcome.
Interventions
patients will undergo an evaluation of their outcome at 30 days postoperatively
Sponsors
Study design
Eligibility
Inclusion criteria
* All children and adults with congenital heart disease
Exclusion criteria
* Parental or patient refusal * Patients presenting for cardiac interventions
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| The prevalence of patients with congenital heart disease presenting for non-cardiac interventions in a single-centre tertiary hospital | Intraoperative | To analyze the exact number of children and adults with congenital heart disease presenting for non-cardiac interventions in a tertiary hospital |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| To analyze morbidity after non-cardiac interventions in patients with congenital heart disease | 30 days | Morbidity outcome after non-cardiac interventions |
| To analyze mortality after non-cardiac interventions in patients with congenital heart disease | 30 days | Mortality outcome after non-cardiac interventions |
Countries
Belgium